Get startedLog in
    Picture of Kazia Therapeutics logo

    KZA — Kazia Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    All News

    Brief: PNOC Clinical Study Of Kazia's Paxalisib In Childhood Brain Cancer Expands Internationally

    Picture of Kazia Therapeutics logoKazia Therapeutics
    06/10/2022 13:43
    Oct 6 (Reuters) - Kazia Therapeutics Ltd  KZA.AX :
    * PNOC CLINICAL STUDY OF KAZIA'S PAXALISIB IN CHILDHOOD
BRAIN
CANCER EXPANDS INTERNATIONALLY
    * KAZIA THERAPEUTICS LTD - KAZIA ANTICIPATES INITIAL DATA
FROM
ONGOING PNOC022 STUDY IN CY2023

Source text for Eikon:  ID:nPnblmJgTa 
Further company coverage:  KZA.AX 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Kazia Therapeutics

    See all news